S4.5c Using serum beta-glucan measurements and sequencing of the Madurella mycetomatis azole target gene to predict therapeutic outcome during azole treatment in human mycetoma

S4.5 MYCETOMA CLINICAL TRIAL ON FOSRAVUCONAZOLE TREATMENT IN EUMYCETOMA– TOP LINE RESULTS, SEPTEMBER 22, 2022, 10:30 AM - 12:00 PM:   OBJECTIVES: Eumycetoma is a neglected tropical disease characterized by large subcutaneous swellings and the formation of grains and most commonly caused by Madurella...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyuykonge, Bertrand, Siddig, Emmanuel, Mhmoud, Najwa, Nyaoke, Borna, Zijlstra, Ed, Verbon, Annelies, Bakhiet, Sahar, Fahal, Ahmed, Van de Sande, Wendy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Oral Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516349/
http://dx.doi.org/10.1093/mmy/myac072.S4.5c

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516349/
http://dx.doi.org/10.1093/mmy/myac072.S4.5c

Ejemplares similares